| 臺大學術典藏 |
2021-06-24T07:16:17Z |
Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
|
Chiu N.-C.; LI-MIN HUANG; Willemsen A.; Bhusal C.; Arora A.K.; Reynoso Mojares Z.; Toneatto D. |
| 臺大學術典藏 |
2021-07-15T05:31:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu, Wang Da; Huang, Yu Shan; Lin, Yi Jiun; Hsieh, Erh Fang; Lian, Wei Cheng; Chen, Charles; Janssen, Robert; Shih, Shin Ru; Huang, Chung Guei; Tai, I. Chen; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; YU-SHAN HUANG; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-02T05:41:26Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; WANG-DA LIU; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T04:24:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2018-09-10T09:13:16Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang, Pan-Chyr;Yu, Chong-Jen;Chang, Shan-Chwen;Hsieh, Szu-Min;Drame, Mamadou;Walravens, Karl;Roman, Francois;Gillard, Paul; Yang, P.-C. and Yu, C.-J. and Chang, S.-C. and Hsieh, S.-M. and Drame, M. and Walravens, K. and Roman, F. and Gillard, P.; 張上淳 ;楊泮池 ;余忠仁 ;謝思民; Yang, Pan-Chyr; Chong-Jen Yu; Yu, Chong-Jen; SZU-MIN HSIEH; SHAN-CHWEN CHANG; Chang, Shan-Chwen; Hsieh, Szu-Min; Drame, Mamadou; Walravens, Karl; Roman, Francois; Gillard, Paul |
| 臺大學術典藏 |
2020-12-02T02:34:00Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
PAN-CHYR YANG; Yu C.-J.; Chang S.-C.; Hsieh S.-M.; Drame M.; Walravens K.; Roman F.; Gillard P. |
| 臺大學術典藏 |
2020-12-29T06:37:40Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Drame M.; Walravens K.; SZU-MIN HSIEH; Chang S.-C.; Yu C.-J.; Yang P.-C.; Roman F.; Gillard P. |
| 臺大學術典藏 |
2022-06-27T07:02:07Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang P.-C.; CHONG-JEN YU; Chang S.-C.; Hsieh S.-M.; Drame M.; Walravens K.; Roman F.; Gillard P. |
| 國立臺灣大學 |
2012 |
Safety and immunogenicity of a split-virion AS03(A)-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang, Pan-Chyr; Yu, Chong-Jen; Chang, Shan-Chwen; Hsieh, Szu-Min; Drame, Mamadou; Walravens, Karl; Roman, Francois; Gillard, Paul; 張上淳; 楊泮池; 余忠仁; 謝思民 |
| 國立臺灣大學 |
2011 |
Safety and Immunogenicity of a Tetravalent Meningococcal Serogroups a, C, W-135 and Y Conjugate Vaccine in Adolescents and Adults
|
黃立民; 林奏延; HUANG, LI-MIN; LIN, TZOU-YIEN |
| 臺大學術典藏 |
2021-06-24T07:16:54Z |
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
|
Bermal N.; LI-MIN HUANG; Dubey A.P.; Jain H.; Bavdekar A.; Lin T.-Y.; Bianco V.; Baine Y.; Miller J.M. |
| 國立臺灣大學 |
2009 |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine against Meningococcal Disease
|
邵蓓嵐; 張鑾英; 謝思民; 張上淳; 盤松青; 呂俊毅; 謝育嘉; 李慶雲; 黃立民; SHAO, PEI-LAN; CHANG, LUAN-YIN; HSIEH, SZU-MIN; CHANG, SHAN-CHWEN; PAN, SUNG-CHING; LU, CHUN-YI; HSIEH, YU-CHIA; LEE, CHIN-YUN; HUANG, LI-MIN |
| 臺大學術典藏 |
2018-09-10T07:37:54Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Shao, PL;Chang, LY;Hsieh, SM;Chang, SC;Pan, SC;Lu, CY;Hsieh, YC;Lee, CY;Dobbelaere, K;Boutriau, D;Tang, H;Bock, HL;Huang, LM; Shao, P.-L. and Chang, L.-Y. and Hsieh, S.-M. and Chang, S.-C. and Pan, S.-C. and Lu, C.-Y. and Hsieh, Y.-C. and Lee, C.-Y. and Dobbelaere, K. and Boutriau, D. and Tang, H. and Bock, H.L. and Huang, L.-M.; Shao, PL; LUAN-YIN CHANG; SZU-MIN HSIEH; Chang, LY; Tang, H; Bock, HL; Huang, LM; Hsieh, SM; LI-MIN HUANG; Chang, SC; CHUN-YI LU; SHAN-CHWEN CHANG; Pan, SC; CHIN-YUN LEE; Lu, CY; Hsieh, YC; SUNG-CHING PAN; Lee, CY; Dobbelaere, K; Boutriau, D |
| 臺大學術典藏 |
2009 |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Lee C.-Y.; Hsieh Y.-C.; Chang L.-Y.; Hsieh S.-M.; Chang S.-C.; SUNG-CHING PAN; Lu C.-Y.; Shao P.-L.; Shao P.-L.;Chang L.-Y.;Hsieh S.-M.;Chang S.-C.;Sung-Ching Pan;Lu C.-Y.;Hsieh Y.-C.;Lee C.-Y.;Dobbelaere K.;Boutriau D.;Tang H.;Bock H.L.;Huang L.-M.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; Huang L.-M. |
| 臺大學術典藏 |
2020-12-15T07:42:19Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Shao P.-L.; LUAN-YIN CHANG; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; Lu C.-Y.; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; Huang L.-M. |
| 臺大學術典藏 |
2009 |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Huang L.-M.; Tang H.; Bock H.L.; Boutriau D.; Dobbelaere K.; Lee C.-Y.; Hsieh Y.-C.; Lu C.-Y.; Pan S.-C.; Chang S.-C.; SZU-MIN HSIEH; Chang L.-Y.; Shao P.-L. |
| 臺大學術典藏 |
2021-01-08T02:16:23Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Chang L.-Y.; Shao P.-L.; Shao P.-L.;Chang L.-Y.;Hsieh S.-M.;Chang S.-C.;Pan S.-C.;Chun-Yi Lu;Hsieh Y.-C.;Lee C.-Y.;Dobbelaere K.;Boutriau D.;Tang H.;Bock H.L.;Huang L.-M.; Huang L.-M.; Bock H.L.; Tang H.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; CHUN-YI LU; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D. |
| 臺大學術典藏 |
2021-05-06T08:26:14Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
PEI-LAN SHAO; Chang L.-Y.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; Lu C.-Y.; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; Huang L.-M. |
| 臺大學術典藏 |
2021-06-24T07:17:01Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Shao P.-L.; Chang L.-Y.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; Lu C.-Y.; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D.; Tang H.; Bock H.L.; LI-MIN HUANG |
| 國立臺灣大學 |
2009-06 |
Safety and immunogenicity of a tetravalent polysaccharide vaccine against meningococcal disease.
|
Shao, PL; Chang, LY; Hsieh, SM; Chang, SC; Pan, SC; Lu, CY; Hsieh, YC; Lee, CY; Dobbelaere, K; Boutriau, D; Tang, H; Bock, HL; Huang, LM |
| 臺大學術典藏 |
2020-09-29T01:47:35Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Wu U.-I.; Hsieh S.-M.; Lee W.-S.; Wang N.-C.; Kung H.-C.; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:01Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Wu U.-I.; Hsieh S.-M.; Lee W.-S.; Wang N.-C.; Kung H.-C.; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2020-12-24T08:57:01Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Ou T.-Y.; Kung H.-C.; Wang N.-C.; Lee W.-S.; Hsieh S.-M.; UN-IN WU; Un-In Wu;Hsieh S.-M.;Lee W.-S.;Wang N.-C.;Kung H.-C.;Ou T.-Y.;Chen F.-L.;Lin T.-Y.;Chen Y.-C.;Chang S.-C.; Chang S.-C.; Chen F.-L.; Lin T.-Y.; Chen Y.-C. |
